Unresolved Systemic Inflammation, Long COVID, and the Common Pathomechanisms of Somatic and Psychiatric Comorbidity

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Sep 9

PMID 36079040

Authors

Chih-Sung Liang

Piotr Galecki

Kuan-Pin Su

Affiliations

Soon will be listed here.

Abstract

Monoamine hypothesis is an overestimated hypothesis of major depressive disorder (MDD), and the treatments and biomarkers that target it only show modest effect in randomized controlled trials+ (RCTs) or case-control studies [...].

Citing Articles

Pharmacological mechanism of Shaoyao Gancao Decoction in the treatment of depression based on bioinformatics and animal experiment.

Li L, Wang J, Ma S, Zheng M, Wang F, Guo X Heliyon. 2025; 10(15):e34865.

PMID: 39959777 PMC: 11829096. DOI: 10.1016/j.heliyon.2024.e34865.

Evaluating the Feasibility, Acceptance, and Beneficial Effects of Online Occupational Therapy for Post-COVID-19 Condition: Protocol for a Randomized Controlled Trial (ErgoLoCo Study).

Mullenmeister C, Stoelting A, Schroder D, Schmachtenberg T, Ritter S, El-Sayed I JMIR Res Protoc. 2024; 13:e50230.

PMID: 38739435 PMC: 11130769. DOI: 10.2196/50230.

Traumatic Brain Injury in the Long-COVID Era.

Agoston D Neurotrauma Rep. 2024; 5(1):81-94.

PMID: 38463416 PMC: 10923549. DOI: 10.1089/neur.2023.0067.

Emotional control in selected somatic and psychiatric diseases.

Orzechowska A, Maruszewska P, Galecka M, Hyland P, Boduszek D, Galecki P BMC Psychiatry. 2023; 23(1):802.

PMID: 37924065 PMC: 10623861. DOI: 10.1186/s12888-023-05321-7.

Integrative bioinformatics and artificial intelligence analyses of transcriptomics data identified genes associated with major depressive disorders including .

Bouzid A, Almidani A, Zubrikhina M, Kamzanova A, Ilce B, Zholdassova M Neurobiol Stress. 2023; 26:100555.

PMID: 37583471 PMC: 10423927. DOI: 10.1016/j.ynstr.2023.100555.

References

Rawdin B, Mellon S, Dhabhar F, Epel E, Puterman E, Su Y . Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun. 2012; 31:143-52. PMC: 3669232. DOI: 10.1016/j.bbi.2012.11.011. View

Schwartz D, Bonelli M, Gadina M, OShea J . Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat Rev Rheumatol. 2015; 12(1):25-36. PMC: 4688091. DOI: 10.1038/nrrheum.2015.167. View

Wachowska K, Galecki P, Szemraj J, Smigielski J, Orzechowska A . Personality Traits and Inflammation in Depressive Disorders. J Clin Med. 2022; 11(7). PMC: 8999769. DOI: 10.3390/jcm11071974. View

Morais L, Schreiber 4th H, Mazmanian S . The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2020; 19(4):241-255. DOI: 10.1038/s41579-020-00460-0. View

Wachowska K, Szemraj J, Smigielski J, Galecki P . Inflammatory Markers and Episodic Memory Functioning in Depressive Disorders. J Clin Med. 2022; 11(3). PMC: 8837175. DOI: 10.3390/jcm11030693. View

Miller A, Raison C . The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2015; 16(1):22-34. PMC: 5542678. DOI: 10.1038/nri.2015.5. View

Wang S, Su K, Pariante C . The three frontlines against COVID-19: Brain, Behavior, and Immunity. Brain Behav Immun. 2021; 93:409-414. PMC: 7857976. DOI: 10.1016/j.bbi.2021.01.030. View

. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021; 398(10312):1700-1712. PMC: 8500697. DOI: 10.1016/S0140-6736(21)02143-7. View

Lee M, Perl D, Nair G, Li W, Maric D, Murray H . Microvascular Injury in the Brains of Patients with Covid-19. N Engl J Med. 2020; 384(5):481-483. PMC: 7787217. DOI: 10.1056/NEJMc2033369. View

10.

Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P . Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet. 2022; 399(10328):957-1022. DOI: 10.1016/S0140-6736(21)02141-3. View

11.

Ting B, Tsai C, Hsu W, Shen M, Tseng P, Chen D . Music Intervention for Pain Control in the Pediatric Population: A Systematic Review and Meta-Analysis. J Clin Med. 2022; 11(4). PMC: 8877634. DOI: 10.3390/jcm11040991. View

12.

Rush A, Trivedi M, Wisniewski S, Nierenberg A, Stewart J, Warden D . Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006; 163(11):1905-17. DOI: 10.1176/ajp.2006.163.11.1905. View

13.

Yang C, Chang C, Yang C, Pariante C, Su K . Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun. 2022; 103:19-27. PMC: 8977215. DOI: 10.1016/j.bbi.2022.04.001. View

14.

Malhi G, Mann J . Depression. Lancet. 2018; 392(10161):2299-2312. DOI: 10.1016/S0140-6736(18)31948-2. View

15.

Chang J, Su K . Nutrition and immunology in mental health: Precision medicine and integrative approaches to address unmet clinical needs in psychiatric treatments. Brain Behav Immun. 2019; 85:1-3. DOI: 10.1016/j.bbi.2019.09.022. View

16.

Chen L, Qu L, Hong R . Pathways Linking the Big Five to Psychological Distress: Exploring the Mediating Roles of Stress Mindset and Coping Flexibility. J Clin Med. 2022; 11(9). PMC: 9105170. DOI: 10.3390/jcm11092272. View

17.

Allison D, Ditor D . The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J Neuroinflammation. 2014; 11:151. PMC: 4156619. DOI: 10.1186/s12974-014-0151-1. View

18.

Marshall M . How COVID-19 can damage the brain. Nature. 2020; 585(7825):342-343. DOI: 10.1038/d41586-020-02599-5. View

19.

Wachowska K, Galecki P . Inflammation and Cognition in Depression: A Narrative Review. J Clin Med. 2021; 10(24). PMC: 8706670. DOI: 10.3390/jcm10245859. View

20.

Kato T . Coping with Stress, Executive Functions, and Depressive Symptoms: Focusing on Flexible Responses to Stress. J Clin Med. 2021; 10(14). PMC: 8304560. DOI: 10.3390/jcm10143122. View